THOMPSON SIEGEL & WALMSLEY LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q1 2017$155,000
-78.0%
33,334
-71.1%
0.00%
-77.8%
Q4 2016$703,000
-8.3%
115,434
-17.1%
0.01%
-25.0%
Q3 2016$767,000
+23.5%
139,234
-14.8%
0.01%
+20.0%
Q2 2016$621,000
-40.4%
163,334
-56.7%
0.01%
+25.0%
Q1 2016$1,042,000
-2.7%
377,368
+99.8%
0.01%
-57.9%
Q4 2015$1,071,000
+6.5%
188,834
-0.5%
0.02%0.0%
Q3 2015$1,006,000
-47.3%
189,834
-17.5%
0.02%
-44.1%
Q2 2015$1,909,000
+45.7%
230,034
-18.9%
0.03%
+47.8%
Q1 2015$1,310,000
+49.9%
283,634
-1.0%
0.02%
+35.3%
Q4 2014$874,000
+5.9%
286,534
-3.3%
0.02%
+6.2%
Q3 2014$825,000
-24.0%
296,284
+11.1%
0.02%
-23.8%
Q2 2014$1,086,000
-20.7%
266,784
+3.5%
0.02%
-32.3%
Q1 2014$1,369,000
+18.1%
257,734
+25.1%
0.03%
+14.8%
Q4 2013$1,159,000
+36.7%
205,950
+11.1%
0.03%
+50.0%
Q3 2013$848,000
+29.3%
185,450
+22.1%
0.02%
+28.6%
Q2 2013$656,000151,9000.01%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2013
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 477,621$1,065,0001.44%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,804$3,358,0001.18%
Nantahala Capital Management 7,000,000$15,610,0000.69%
Hikari Power Ltd 1,900,000$4,237,0000.50%
Trellus Management Company, LLC 112,500$251,0000.34%
Cheyne Capital Management (UK) LLP 206,500$462,0000.20%
KNOTT DAVID M 201,400$449,0000.18%
Paulson & Co. 4,000,000$8,920,0000.17%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,041,695$2,323,0000.15%
Clear Harbor Asset Management, LLC 318,460$710,0000.13%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders